Global Think-Tank on Steatotic Liver Disease

Our Mission
To connect science, policy, care—and people—in advancing global recognition of steatotic liver disease (SLD)—especially metabolic dysfunction-associated SLD (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)—as a key component of the metabolic health crisis.

We foster inclusive dialogue across disciplines and lived experiences, expand a diverse community of practice, and accelerate the integration of liver health into national and global non-communicable disease (NCD) agendas.

Our Vision
A future where steatotic liver disease is a recognised global health priority—addressed through early diagnosis, prevention, and equitable treatment and care. By 2030, liver health is fully embedded within city, national and global NCD strategies, contributing to fewer preventable deaths, reduced health inequities, and stronger, more integrated responses to metabolic disease worldwide.